25/10/2023 Eisai plans to submit a biologics license application for a subcutaneous formulation of lecanemab to the FDA Science watch
24/10/2023 Phase 2 trial of ABvac40 vaccine reports positive results at CTAD, showing a robust immune response and potential cognitive benefits in very early AD Science watch
28/09/2023 New study suggests there may be a link between concussion early in life and cognitive decline in later life Science watch
27/09/2023 Ionis Pharmaceuticals and Roche enter new partnership for two novel programmes for Alzheimer's and Huntington's diseases Science watch
26/09/2023 Synaptogenix reports new findings from its Phase II trial of Bryostatin-1 in AD Science watch
21/09/2023 Alzheimer’s Disease Data Initiative announces its inaugural cohort of William H. Gates Sr. Fellows Science watch
21/09/2023 Findings from the A4 Study of solanezumab for preclinical AD have been published Science watch
18/09/2023 RECOGNISED convenes all project partners for its annual General Assembly meeting Science watch
14/09/2023 Anavex reports follow-on analysis data from its Phase IIb/III study of blarcamesine in early AD Science watch
13/09/2023 Alzheon reports positive findings from its Phase II trial of ALZ-801 for early AD Science watch
